Literature DB >> 32505561

Selective Neck Dissection Guided by a Radioactive I125 Seed for Papillary Thyroid Carcinoma Recurrence.

Alberto Vilar Tabanera1, Odile Ajuria2, María Eugenia Rioja2, Jacobo Cabañas Montero3.   

Abstract

Lymph nodes are the most common place of recurrence of papillary thyroid cancer, and surgery can be considered a therapeutic option. The risks of surgery increase with every intervention. We present 3 cases of cervical non palpable thyroid cancer recurrence managed with I125 seed radioguided cervical dissection from 2017 to 2019. Two of the cases had already a thyroidectomy and central compartment lymphadenectomy performed. The seed was placed guided by US on the lesion and its position was confirmed afterwards. The target was successfully localized in 100% of cases. There was no post surgery complications. There was no evidence of recurrence with a mean follow up of 15 months. Radioguided surgery using I125 seed it is a save technique and it offers a precise localization of the non palpable thyroid cancer recurrence.
Copyright © 2020 AEC. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Carcinoma papilar de tiroides; Cirugía radioguiada; Papillary thyroid carcinoma; Radioguided surgery; Recurrencia cervical; Recurrent cervical cancer

Year:  2020        PMID: 32505561     DOI: 10.1016/j.ciresp.2020.04.018

Source DB:  PubMed          Journal:  Cir Esp (Engl Ed)        ISSN: 2173-5077


  2 in total

1.  A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma.

Authors:  Qingtao Ni; Chi Pan; Qing Guo; Peng Wang; Yan Yang; Wei Zhang; Shengbin Dai
Journal:  Dose Response       Date:  2022-05-19       Impact factor: 2.623

Review 2.  How molecular imaging will enable robotic precision surgery : The role of artificial intelligence, augmented reality, and navigation.

Authors:  Thomas Wendler; Fijs W B van Leeuwen; Nassir Navab; Matthias N van Oosterom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-29       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.